Ongoing Pivotal Study to Evaluate VenoValve® for the Treatment of Chronic Venous Insufficiency

The VenoValve is being developed to help people like you. Let’s find out if you prequalify.

You are not alone

 

Chronic Venous Disease (CVD) is the country’s most prevalent chronic disease impacting an estimated 175 million adults in the U.S. Chronic Venous Insufficiency (CVI) is the largest subset of severe CVD which occurs in approximately 2.5 million people.

 

Positive Results from a Prior Clinical Study

 

Although the study results were very encouraging, there is no guarantee that you will have the same or similar results, that your CVI will improve, and that your condition(s) will not worsen.

Let’s see if you are eligible to prequalify as a candidate
to participate in the SAVVE study.

Please fill out all fields in the below form.

 
 

Do you have (or have you had in the past year) a poorly healing open skin sore on your leg that is located below the knee and near the inner part of the ankle?
Have you been diagnosed as having a DVT (blood clot in the lower leg)?
Is your physical activity limited due to heart disease? (For example, is it difficult to walk short distances?)
Have you been diagnosed with fibromyalgia?
Have you been fully vaccinated for COVID?
Which participating study location is closet to you?


I agree to be contacted (type yes)  

By submitting the above information, you consent to being contacted by a study representative and to receiving clinical updates. You also agree that the information and accompanying photos may be used for pre-screening purposes for the clinical trial and in connection with the development of VenoValve.

Loading...